Standardizing cell therapy processes with Josh Ludwig
In this interview, Josh Ludwig talks about the importance of collaboration and standardization in the development and manufacturing of cell therapies. Josh explains how standardizing processes across the industry can be achieved by sharing expertise and best practices and elaborates on how this could shave months or even years off process development timelines.
He also dives into the key challenges the industry is facing when it comes to the scale-up of cell therapies and gives us an insight into how ScaleReady (MN, USA) is positioned to help solve them.
Meet the speaker
Josh Ludwig leads commercial operations as the Global Director for ScaleReady (MN, USA). He closely collaborates with the EMEA Commercial and Leadership Teams to ensure ScaleReady addresses the longstanding industry need for a truly scalable and practical solution. Josh has more than a decade of experience in commercial leadership and business development in the medical device industry, with a specific focus on engaging directly with customers and achieving customer and company goals.
Before ScaleReady, Josh spent more than seven years supporting technical and business development at Wilson Wolf, a founding partner of ScaleReady. He successfully established protocols and executed all aspects of global business development, customer service and marketing efforts. Josh’s career in the life sciences began by obtaining a Bachelor of Science in biology and a minor in chemistry from the University of St. Thomas (MN, USA).
